Fractional CHRO, Callio Therapeutics
Meredith Wesley brings over 20 years of human resources experience in biotech as well as technology, marketing, and manufacturing industries. She is currently a fractional CHRO with Callio Therapeutics, a clinical stage oncology company developing dual-payload antibody-drug conjugates. Prior to that, she served as CHRO for Boundless Bio, a next-generation precision oncology company, where she led talent and culture from its inception in early drug discovery through rapid growth into clinical development. Prior to that, she was Head of Human Resources at Ignyta, where she was responsible for leading human resources from its startup phase through its $2 billion acquisition by Roche. Meredith also served as senior director, human resources at Santarus, a specialty biopharmaceutical company, where she was responsible for multiple commercial scale-ups during launches in addition to providing HR leadership to commercial and R&D. Meredith holds a bachelor’s degree from the University of San Diego and a Human Resources Management certification from the University of California, Irvine.